GLP-1 Medicaid coverage: what to know in 2026

Medicaid coverage can differ depending on your state and whether you are in fee-for-service Medicaid or a managed care plan. Find your plan name on your member card or in your online account. If you have managed care, the plan’s drug list and rules may differ from the state’s general list. Write down your plan’s member services number so you can call with specific questions.

Ask your plan or pharmacy for the most current formulary and any recent updates, since coverage can change. Use the exact drug name and form when you search: pill vs injection can be treated differently. For example, Wegovy exists as injections and also as a pill (oral semaglutide 25 mg) and they may not be covered the same way. If you are using a “compounded” version, ask how the plan handles it, because many plans do not treat compounded products the same as FDA-approved brand medications.

Many plans require prior authorization, even when a medication is on the formulary. Ask what clinical information the plan expects (for example, diagnosis category and documentation requirements), and whether they require step therapy first. If you are switching products or dosage forms, ask if that triggers a new prior authorization. Your prescriber’s office typically submits this, but you can help by asking the plan what is missing if there is a delay.

Some GLP-1 pills have strict instructions that can affect real-world adherence. Wegovy pill must be taken first thing in the morning with a small sip of water, at least 30 minutes before food, drinks, or other oral medicines. Foundayo (orforglipron) is a once-daily GLP-1 pill that does not require fasting or water restrictions and can be taken any time of day. Coverage is separate from convenience, so confirm both: what your plan covers and what you can realistically follow.

If you are not getting coverage through Medicaid, ask about other options you might qualify for, such as Medicare coverage if you also have Medicare (dual eligibility). As of 2026, CMS is running a temporary Medicare GLP-1 Bridge demonstration (July 1, 2026 to Dec 31, 2027) that covers Wegovy (all forms), Foundayo, and Zepbound KwikPen for eligible Part D enrollees with prior authorization and a $50/month copay. This is Medicare, not Medicaid, but it matters if you have both. Member services or a benefits counselor can tell you which program is paying first and what rules apply.

If you end up self-paying, stick to manufacturer channels and confirm today’s terms. At the time of writing, Foundayo is available via LillyDirect, telehealth, and retail pharmacies, with self-pay starting at $149/month for the lowest dose and a commercial savings card as low as $25/month for eligible patients. Also at the time of writing, TrumpRx.gov lists the lowest manufacturer self-pay prices and routes you to the maker’s channel (it is not insurance and prices change). Always verify current pricing and eligibility directly with the manufacturer, your plan, or your pharmacist before you make a decision.